ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
67,714.86
-0.02%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Interleukin Genetics, (ILI)

  7. Interleukin Genetics, (ILI) News

ILI

Interleukin Genetics (ILI)

Interleukin Genetics,
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ILI
DateTimeSourceHeadlineSymbolCompany
08/12/20103:07PMEdgar (US Regulatory)Quarterly Report (10-Q)AMEX:ILIInterleukin Genetics,
08/05/20103:01PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:ILIInterleukin Genetics,
08/05/20107:49AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ILIInterleukin Genetics,
08/05/20106:02AMEdgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
07/21/20103:30PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
06/25/20104:06PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
06/21/20105:31AMEdgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
05/13/20103:06PMEdgar (US Regulatory)Quarterly Report (10-Q)AMEX:ILIInterleukin Genetics,
05/05/20105:02AMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ILIInterleukin Genetics,
04/30/20106:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
04/30/20106:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ILIInterleukin Genetics,
04/30/20103:36PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
04/30/201012:15PMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ILIInterleukin Genetics,
04/13/20104:04PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)AMEX:ILIInterleukin Genetics,
04/08/20103:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
04/08/20103:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
04/05/20103:35PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)AMEX:ILIInterleukin Genetics,
04/01/20103:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
03/25/20103:13PMEdgar (US Regulatory)Annual Report (10-K)AMEX:ILIInterleukin Genetics,
03/19/20103:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
03/10/20104:11PMEdgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)AMEX:ILIInterleukin Genetics,
03/09/20108:46AMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:ILIInterleukin Genetics,
03/05/20101:52PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)AMEX:ILIInterleukin Genetics,
03/03/20101:04PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
03/01/20104:00PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
02/19/20104:03PMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:ILIInterleukin Genetics,
02/04/20106:00AMPR Newswire (US)Interleukin Genetics to Present at the 12th Annual BIO CEO ConferenceTSXV:ILI
02/03/20103:34PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:ILIInterleukin Genetics,
02/02/20104:01PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
01/25/20103:17PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
 Showing the most relevant articles for your search:AMEX:ILI

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
ENZC
Enzolytics (PK)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
DJT
Trump Media and Technology
NASDAQ
NVDA
NVIDIA
USOTC
ERHE
ERHC Energy (CE)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
CIVX
CTR Investments and Cons... (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
RNVA
Rennova Health (PK)
USOTC
SPZI
Spooz (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
BLEG
Branded Legacy (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
COOP
Mr Cooper
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved